Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $11.9 Million - $17.8 Million
-251,348 Reduced 95.26%
12,493 $847,000
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $4.4 Million - $7.7 Million
-144,907 Reduced 35.45%
263,841 $13.1 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $13.1 Million - $20.2 Million
408,748 New
408,748 $13.3 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Nfj Investment Group, LLC Portfolio

Follow Nfj Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nfj Investment Group, LLC with notifications on news.